Hangzhou Coco Healthcare Products Co.,Ltd.
Shenzhen Stock ExchangeTotal Valuation
Hangzhou Coco Healthcare Products Co.,Ltd. carries a market capitalization of 2.27B, placing it among publicly traded companies globally. Its enterprise value stands at 2.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.27B |
| Enterprise Value | 2.98B |
Share Statistics
Hangzhou Coco Healthcare Products Co.,Ltd. currently has 271.86M shares outstanding.
| Shares Outstanding | 271.86M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Hangzhou Coco Healthcare Products Co.,Ltd. trades at a trailing price-to-earnings ratio of 101.06. The price-to-sales ratio is 3.31, and the price-to-book ratio stands at 6.22.
| PE Ratio | 101.06 |
| PS Ratio | 3.31 |
| PB Ratio | 6.22 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | 84.18 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Hangzhou Coco Healthcare Products Co.,Ltd. trades at an EV/EBITDA multiple of 130.06 and an EV/FCF ratio of 66.88. The EV/Sales ratio of 2.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 130.06 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.70 |
| EV / EBITDA | 130.06 |
| EV / EBIT | 130.06 |
| EV / FCF | 66.88 |
Financial Position
Hangzhou Coco Healthcare Products Co.,Ltd. maintains a current ratio of 2.07, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 11.25, indicating elevated leverage, while an interest coverage ratio of 19.74 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.07 |
| Quick Ratio | 1.45 |
| Debt / Equity | 11.25 |
| Debt / EBITDA | 6.97 |
| Interest Coverage | 19.74 |
Financial Efficiency
Hangzhou Coco Healthcare Products Co.,Ltd. posts a return on equity of 6.23 and a return on invested capital of 1.44.
| Return on Equity (ROE) | 6.23 |
| Return on Assets (ROA) | 1.79 |
| Return on Invested Capital (ROIC) | 1.44 |
| Return on Capital Employed (ROCE) | 5.07 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 6.64 |
Taxes
Over the trailing twelve months, Hangzhou Coco Healthcare Products Co.,Ltd. has paid 2.20M in income taxes, reflecting an effective tax rate of 5.81.
| Income Tax | 2.20M |
| Effective Tax Rate | 5.81 |
Stock Price Statistics
Hangzhou Coco Healthcare Products Co.,Ltd.'s stock has declined approximately -37.44493% over the past 52 weeks. The 50-day moving average sits at 9.87, while the 200-day moving average is 12.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -37.44493% |
| 50-Day Moving Average | 9.87 |
| 200-Day Moving Average | 12.20 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Hangzhou Coco Healthcare Products Co.,Ltd. generated 1.11B in revenue and converted that into 36.24M in net income, yielding earnings per share of 0.13. EBITDA reached 22.93M, while operating income came in at 22.93M.
| Revenue | 1.11B |
| Gross Profit | 241.50M |
| Operating Income | 22.93M |
| Pretax Income | 37.97M |
| Net Income | 36.24M |
| EBITDA | 22.93M |
| EBIT | 22.93M |
| Earnings Per Share (EPS) | 0.13 |
Balance Sheet
Hangzhou Coco Healthcare Products Co.,Ltd. holds 917.28M in cash and equivalents against 159.90M in total debt, resulting in a net debt position of -587.46M. Total book value stands at 588.33M, with working capital of 678.10M providing operational flexibility.
| Cash & Cash Equivalents | 917.28M |
| Total Debt | 159.90M |
| Net Debt | -587.46M |
| Equity (Book Value) | 588.33M |
| Book Value Per Share | 2.21 |
| Working Capital | 678.10M |
Cash Flow
After subtracting -43.50M in capital expenditures, free cash flow totaled -43.50M - equivalent to -0.16 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -43.50M |
| Free Cash Flow | -43.50M |
| FCF Per Share | -0.16 |
Margins
Hangzhou Coco Healthcare Products Co.,Ltd. operates with a gross margin of 21.82, reflecting its pricing power and cost economics. The operating margin of 2.07 and net profit margin of 3.27 provide insight into operational efficiency.
| Gross Margin | 21.82 |
| Operating Margin | 2.07 |
| Pretax Margin | 3.43 |
| Profit Margin | 3.27 |
| EBITDA Margin | 2.07 |
Dividends & Yields
The company's payout ratio of 52.97 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.07 |
| Dividend Yield | N/A |
| Payout Ratio | 52.97 |
| Shareholder Yield | -2.42 |
| FCF Yield | 1.19 |
Scores
Hangzhou Coco Healthcare Products Co.,Ltd. posts an Altman Z-Score of 4.44, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.44 |